相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension
Jing Huang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Preparation and properties of inhalable nanocomposite particles: Effects of the temperature at a spray-dryer inlet upon the properties of particles
Keishiro Tomoda et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2008)
Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension
Olivier Sanchez et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
A nuclear factor-κB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats
Hirofumi Sawada et al.
CHEST (2007)
Stent-based local delivery of nuclear factor-κB decoy attenuates in-stent restenosis in hypercholesterolemic rabbits
Kisho Ohtani et al.
CIRCULATION (2006)
Hypoxia-induced pulmonary vascular remodeling - Cellular and molecular mechanisms
Kurt R. Stenmark et al.
CIRCULATION RESEARCH (2006)
Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension
T Itoh et al.
RESPIROLOGY (2006)
Reversal of experimental pulmonary hypertension by PDGF inhibition
RT Schermuly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Epoprostenol therapy decreases elevated circulating levels of monocyte chemoattractant protein-1 in patients with primary pulmonary hypertension
K Hashimoto et al.
CIRCULATION JOURNAL (2004)
Drug therapy: Treatment of pulmonary arterial hypertension
M Humbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Antimonocyte chemoattractant protein-1 gene therapy reduces experimental in-stent restenosis in hypercholesterolemic rabbits and monkeys
K Ohtani et al.
GENE THERAPY (2004)
Mechanisms of disease: Pulmonary arterial hypertension
HW Farber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Pressure-induced vascular activation of nuclear factor-κB -: Role in cell survival
CA Lemarié et al.
CIRCULATION RESEARCH (2003)
Molecular mechanisms mediating inflammation in vascular disease - Special reference to monocyte chemoattractant protein-1
K Egashira
HYPERTENSION (2003)
Anti-monocyte chemoattractant protein-1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeys
M Usui et al.
FASEB JOURNAL (2002)
Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats
Y Ikeda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles:: implications for drug and gene delivery
J Panyam et al.
FASEB JOURNAL (2002)
Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys
K Egashira et al.
CIRCULATION RESEARCH (2002)
Clinical importance of endothelial function in arteriosclerosis and ischemic heart disease
K Egashira
CIRCULATION JOURNAL (2002)
eNOS-deficient mice show reduced pulmonary vascular proliferation and remodeling to chronic hypoxia
TR Quinlan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2000)
Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor
KN Cowan et al.
NATURE MEDICINE (2000)
分享论文
